General Announcement::Press Release: iX Biopharma inks agreement with Cannatrek to supply Xativa to the Australian market

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
29-Apr-2020 07:47:48
Status
New
Announcement Sub Title
Press Release: iX Biopharma inks agreement with Cannatrek to supply Xativa to the Australian market
Announcement Reference
SG200429OTHROQQ5
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

IXBIO - Press Release - iX and Cannatrek Supply Agreement.pdf
Total size =142K